Related Research Articles
John James Rickard Macleod,, was a Scottish biochemist and physiologist. He devoted his career to diverse topics in physiology and biochemistry, but was chiefly interested in carbohydrate metabolism. He is noted for his role in the discovery and isolation of insulin during his tenure as a lecturer at the University of Toronto, for which he and Frederick Banting received the 1923 Nobel prize in Physiology or Medicine.
Bernardo Alberto Houssay was an Argentine physiologist. Houssay was a co-recipient of the 1947 Nobel Prize for Physiology or Medicine for discovering the role played by pituitary hormones in regulating the amount of glucose in animals, sharing the prize with Carl Ferdinand Cori and Gerty Cori. He is the first Latin American Nobel laureate in the sciences.
Schack August Steenberg Krogh was a Danish professor at the department of zoophysiology at the University of Copenhagen from 1916 to 1945. He contributed a number of fundamental discoveries within several fields of physiology, and is famous for developing the Krogh Principle.
Rosalyn Sussman Yalow was an American medical physicist, and a co-winner of the 1977 Nobel Prize in Physiology or Medicine for development of the radioimmunoassay technique. She was the second woman, and the first American-born woman, to be awarded the Nobel Prize in Physiology or Medicine.
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares.
An insulin analog is any of several types of medical insulin that are altered forms of the hormone insulin, different from any occurring in nature, but still available to the human body for performing the same action as human insulin in terms of controlling blood glucose levels in diabetes. Through genetic engineering of the underlying DNA, the amino acid sequence of insulin can be changed to alter its ADME characteristics. Officially, the U.S. Food and Drug Administration (FDA) refers to these agents as insulin receptor ligands, although they are usually just referred to as insulin analogs or even just insulin.
Neutral Protamine Hagedorn (NPH) insulin, also known as isophane insulin, is an intermediate-acting insulin given to help control blood sugar levels in people with diabetes. It is used by injection under the skin once to twice a day. Onset of effects is typically in 90 minutes and they last for 24 hours. Versions are available that come premixed with a short-acting insulin, such as regular insulin.
Matthias Mann is a German physicist and biochemist. He is doing research in the area of mass spectrometry and proteomics.
Hans Christian Jacobaeus was a Swedish internist born in Skarhult.
Hans Christian Hagedorn was the creator of NPH insulin and the founder of Nordisk Insulinlaboratorium, which is known today as Novo Nordisk.
Mark Atkinson is an American medical researcher best known for his contributions to research seeking to predict, prevent, and cure type 1 diabetes. He is the author of over 600 publications and is one of the world's most cited diabetes researchers.
Carl Ronald Kahn is an American physician and scientist, best known for his work with insulin receptors and insulin resistance in diabetes and obesity. He is the Chief Academic Officer at Joslin Diabetes Center, the Mary K. Iacocca Professor of Medicine at Harvard Medical School and a member of the National Academy of Sciences since 1999.
The Novo Nordisk Foundation is an international enterprise foundation focusing on medical treatment and research.
Gökhan S. Hotamisligil is a Turkish-American physician scientist; James Stevens Simmons Chair of Genetics and Metabolism at Harvard T.H. Chan School of Public Health (HSPH); Director of the Sabri Ülker Center for Metabolic Research and associate member of Harvard-MIT Broad Institute, Harvard Stem Cell Institute and the Joslin Diabetes Center.
Avideh Nazeri is an Iranian endocrinologist who is director of clinical, medical, and regulatory for Novo Nordisk UK and Ireland.
Drew Weissman is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).
Mads Krogsgaard Thomsen is a Danish businessman, CEO of the Novo Nordisk Foundation and former Executive Vice President of Research & Development, head of R&D and Chief Scientific Officer (CSO) at the pharmaceutical company Novo Nordisk.
The Novo Nordisk Prize is an annual award presented to acknowledge exceptional contributions within the fields of medical and health sciences. It is specifically aimed at individuals who have demonstrated outstanding research or innovation that has the potential to advance medical science, particularly in areas related to diabetes, endocrinology, and biopharmaceutical science. The prize is administered by the Novo Nordisk Foundation, an independent Danish foundation with a broad commitment to scientific research and humanitarian objectives.
The Novozymes Prize is an annual scientific award. The prize aims to recognise outstanding contributions to the advancement of science within the fields of biotechnology and bioinnovation.
The Jacobaeus Prize, (also known as the "Jacobæus Prize") is regarded as a prestigious recognition within the field of medical research. It is an annual award given to individuals who have made significant contributions to the advancement of medical science, particularly in the areas of physiology or endocrinology.
References
- ↑ "Crash course – 2023 Nobel Prizes". NobelPrize.org. 27 November 2023. Retrieved 2024-04-09.
- ↑ Bærnholdt. "History". Steno Website. Retrieved 2024-04-09.
- ↑ "The Hagedorn Medal and Prize". Research Explorer The University of Manchester. Retrieved 2024-04-09.
- ↑ Rydén, Lars; Lindsten, Jan (May 2021). "The history of the Nobel prize for the discovery of insulin". Diabetes Research and Clinical Practice. 175: 108819. doi:10.1016/j.diabres.2021.108819. PMID 33865917.
- 1 2 3 "The Hagedorn Prize". Novo Nordisk Fonden. Retrieved 2024-04-09.
- ↑ "Internationally acclaimed Danish virologist receives the 2022 Hagedorn Prize". Novo Nordisk Fonden. Retrieved 2024-04-09.
- ↑ "Prize recipients Archive". Novo Nordisk Fonden. Retrieved 2024-04-09.
- ↑ Malassé, Charlotte (2022-03-03). "Internationally acclaimed Danish virologist receives the 2022 Hagedorn Prize". isim.ku.dk. Retrieved 2024-04-09.